Saien Lu

667 total citations · 1 hit paper
20 papers, 426 citations indexed

About

Saien Lu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Saien Lu has authored 20 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Saien Lu's work include Ubiquitin and proteasome pathways (5 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Autophagy in Disease and Therapy (4 papers). Saien Lu is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Autophagy in Disease and Therapy (4 papers). Saien Lu collaborates with scholars based in China, Saint Kitts and Nevis and United States. Saien Lu's co-authors include Naijin Zhang, Yingxian Sun, Shilong You, Boquan Wu, Liu Cao, Jiaqi Xu, Xinyue Huang, Ying Zhang, Shaojun Wu and Jingwei Liu and has published in prestigious journals such as Circulation Research, Biochemical and Biophysical Research Communications and Cell Research.

In The Last Decade

Saien Lu

17 papers receiving 422 citations

Hit Papers

α-myosin heavy chain lactylation maintains sarcomeric str... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saien Lu China 11 273 83 68 65 58 20 426
Boquan Wu China 13 357 1.3× 107 1.3× 81 1.2× 79 1.2× 60 1.0× 23 548
Shilong You China 14 374 1.4× 115 1.4× 95 1.4× 82 1.3× 59 1.0× 23 576
Xinyue Huang China 9 207 0.8× 72 0.9× 41 0.6× 43 0.7× 46 0.8× 25 352
Yuanming Zou China 8 227 0.8× 89 1.1× 32 0.5× 36 0.6× 61 1.1× 14 363
Fahmida Rasha United States 10 119 0.4× 69 0.8× 85 1.3× 68 1.0× 38 0.7× 15 334
Antoinette Bugyei‐Twum Canada 9 195 0.7× 37 0.4× 52 0.8× 53 0.8× 158 2.7× 11 416
Jared T. Field Canada 8 199 0.7× 101 1.2× 37 0.5× 133 2.0× 33 0.6× 12 358
Qiuju Fan China 11 279 1.0× 104 1.3× 67 1.0× 61 0.9× 10 0.2× 17 387
Caolitao Qin China 11 375 1.4× 75 0.9× 52 0.8× 83 1.3× 14 0.2× 15 554

Countries citing papers authored by Saien Lu

Since Specialization
Citations

This map shows the geographic impact of Saien Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saien Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saien Lu more than expected).

Fields of papers citing papers by Saien Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saien Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saien Lu. The network helps show where Saien Lu may publish in the future.

Co-authorship network of co-authors of Saien Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Saien Lu. A scholar is included among the top collaborators of Saien Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saien Lu. Saien Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Xu, Mingliang, Wenbin Wang, Saien Lu, et al.. (2025). The advances in acetylation modification in senescence and aging-related diseases. Frontiers in Physiology. 16. 1553646–1553646.
4.
Li, Yanqiu, et al.. (2024). Progress in diagnosis and treatment of hypertension combined with left ventricular hypertrophy. Annals of Medicine. 56(1). 2405080–2405080.
5.
Lu, Saien, et al.. (2024). Construction and validation of a nomogram to predict left ventricular hypertrophy in low‐risk patients with hypertension. Journal of Clinical Hypertension. 26(3). 274–285. 3 indexed citations
6.
Zhang, Ying, Naijin Zhang, Yuanming Zou, et al.. (2023). Deacetylation of Septin4 by SIRT2 (Silent Mating Type Information Regulation 2 Homolog-2) Mitigates Damaging of Hypertensive Nephropathy. Circulation Research. 132(5). 601–624. 28 indexed citations
7.
Zhang, Naijin, Ying Zhang, Jiaqi Xu, et al.. (2023). α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure. Cell Research. 33(9). 679–698. 150 indexed citations breakdown →
8.
You, Shilong, Shu Zhang, Linlin Zhang, et al.. (2023). Atorvastatin rescues vascular endothelial injury in hypertension by WWP2-mediated ubiquitination and degradation of ATP5A. Biomedicine & Pharmacotherapy. 166. 115228–115228. 3 indexed citations
9.
Zhang, Naijin, Ying Zhang, Wei Miao, et al.. (2022). An unexpected role for BAG3 in regulating PARP1 ubiquitination in oxidative stress-related endothelial damage. Redox Biology. 50. 102238–102238. 26 indexed citations
10.
Xu, Jiaqi, Saien Lu, Shilong You, et al.. (2022). The regulatory roles of the E3 ubiquitin ligase NEDD4 family in DNA damage response. Frontiers in Physiology. 13. 968927–968927. 10 indexed citations
11.
Huang, Xinyue, Saien Lu, Shilong You, et al.. (2022). The role of E3 ubiquitin ligase WWP2 and the regulation of PARP1 by ubiquitinated degradation in acute lymphoblastic leukemia. Cell Death Discovery. 8(1). 421–421. 7 indexed citations
12.
Zhang, Naijin, Ying Zhang, Boquan Wu, et al.. (2021). Deacetylation-dependent regulation of PARP1 by SIRT2 dictates ubiquitination of PARP1 in oxidative stress-induced vascular injury. Redox Biology. 47. 102141–102141. 39 indexed citations
13.
Wu, Boquan, Shilong You, Saien Lu, et al.. (2021). DNA Polymerase Gamma Recovers Mitochondrial Function and Inhibits Vascular Calcification by Interacted with p53. International Journal of Biological Sciences. 18(1). 409–425. 5 indexed citations
14.
Wu, Shaojun, Ying Zhang, Shilong You, et al.. (2021). Septin4 promotes cardiomyocytes apoptosis by enhancing the VHL-mediated degradation of HIF-1α. Cell Death Discovery. 7(1). 172–172. 5 indexed citations
15.
Wu, Boquan, Shilong You, Hao Qian, et al.. (2021). The role of SIRT2 in vascular‐related and heart‐related diseases: A review. Journal of Cellular and Molecular Medicine. 25(14). 6470–6478. 29 indexed citations
16.
Zhang, Ying, Shilong You, Saien Lu, et al.. (2020). WWP2 regulates SIRT1‐STAT3 acetylation and phosphorylation involved in hypertensive angiopathy. Journal of Cellular and Molecular Medicine. 24(16). 9041–9054. 18 indexed citations
17.
You, Shilong, Ying Zhang, Jiaqi Xu, et al.. (2020). The Role of BRG1 in Antioxidant and Redox Signaling. Oxidative Medicine and Cellular Longevity. 2020. 1–12. 17 indexed citations
18.
Zhang, Naijin, Ying Zhang, Shilong You, et al.. (2020). Septin4 Prevents PDGF-BB-induced HAVSMC Phenotypic Transformation, Proliferation and Migration by Promoting SIRT1-STAT3 Deacetylation and Dephosphorylation. International Journal of Biological Sciences. 16(4). 708–718. 13 indexed citations
19.
Zhang, Ying, Hao Qian, Boquan Wu, et al.. (2020). E3 Ubiquitin ligase NEDD4 family‑regulatory network in cardiovascular disease. International Journal of Biological Sciences. 16(14). 2727–2740. 58 indexed citations
20.
Wang, Ning, Feng Xu, Saien Lu, Naijin Zhang, & Yingxian Sun. (2020). Septin4 as an autophagy modulator regulates Angiotensin-II mediated VSMCs proliferation and migration. Biochemical and Biophysical Research Communications. 525(2). 272–279. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026